Status:
ENROLLING_BY_INVITATION
Integrating eSAGE With EHR Data Using Machine Learning for the Early Detection and Monitoring of Cognitive Impairment in Individuals
Lead Sponsor:
Douglas Scharre
Conditions:
Dementia
Alzheimer Disease
Eligibility:
All Genders
50+ years
Brief Summary
The goal of this observational trial is to leverage the electronic Self-Administered Gerocognitive Examination (eSAGE), a variety of metadata (a set of data that describes and gives information about ...
Detailed Description
This is a retrospective and prospective record review trial for patients who are followed at the Center for Cognitive and Memory Disorders. eSAGE assessment data (including cognitive data, behavioral...
Eligibility Criteria
Inclusion
- 1\. Males and females 50 years of age and over who complete the eSAGE as part of their office visit at the Center for Cognitive and Memory Disorders.
Exclusion
- None
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
1486 Patients enrolled
Trial Details
Trial ID
NCT06017505
Start Date
September 1 2024
End Date
September 1 2027
Last Update
March 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nicole Vrettos
Columbus, Ohio, United States, 43123